According to CASI Pharmaceuticals's latest financial reports the company's current earnings are S$23.1 Million. In 2023 the company made an earning of -S$35.41 Million, an increase over its 2022 earnings that were of -S$50.26 Million. The earnings displayed on this page is the company's Pretax Income.